NeOnc Technologies Holdings is trading at $3.14, up +5.02% in pre-market; available coverage identified no company-specific announcement explaining the October 5 rise. - The latest identified company news was September 28: a planned November 17 FDA meeting about NEO212. That announcement does not establish a direct cause for this move. - Major U.S. indices were only slightly lower in the supplied market context. No volume or activity-level data was provided.